MedTrace Logo

Creatine Supplementation During Resistance Training for People Recovering From Stroke

NCT03941678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-06-11

No results posted yet for this study

Summary

Creatine monohydrate is important for sustaining phosphocreatine stores in tissues such as muscle and brain. Phosphocreatine is an important source of energy in these tissues. Supplementation with creatine monohydrate is effective in healthy and clinical populations for improving muscle and brain function. The purpose of our study is to determined whether creatine supplementation is effective during resistance training for improving muscle and brain function in people recovering from stroke.

Conditions

Interventions

DIETARY_SUPPLEMENT

Creatine monohydrate

0.3 g/kg/day for 7 days; 0.1 g/kg/day for 63 days

DIETARY_SUPPLEMENT

Placebo

0.3 g/kg/day for 7 days; 0.1 g/kg/day for 63 days

Sponsors & Collaborators

  • University of Regina

    collaborator OTHER

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Philip Chilibeck, Ph.D. · University of Saskatchewan

  • Darren Candow, Ph.D. · University of Regina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-30
Primary Completion
2019-12-30
Completion
2020-05-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03941678 on ClinicalTrials.gov